|
|
|
|
|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
Development, Vol 127, Issue 24 5379-5389, Copyright © 2000 by Company of Biologists
JOURNAL ARTICLES |
L Hou, JJ Panthier and H Arnheiter
Laboratory of Developmental Neurogenetics, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892, USA.
Genetic and cell culture analyses have shown that the development of melanocytes from neural crest-derived precursor cells critically depends on the tyrosine kinase receptor KIT and the basic-helix-loop-helix-leucine zipper transcription factor MITF. KIT and MITF show complex interactions in that MITF is needed for the maintenance of Kit expression in melanoblasts and KIT signaling modulates MITF activity and stability in melanocyte cell lines. Using primary neural crest cell cultures from embryos homozygous for a Kit null allele marked by an inserted LacZ gene (Kit(W-LacZ)), we show that the onset of Mitf expression in melanoblasts does not require KIT. In fact, provided that the melanocyte growth factor endothelin-3 is present, a small number of MITF/beta-Gal-positive cells can be maintained for at least 2 weeks in Kit(W-LacZ)/Kit(W-LacZ) cultures. These cells express several pigment cell-specific genes that are thought or have been shown to be activated by MITF, including dautochrome tautomerase, pMel 17/Silver and tyrosinase-related protein-1, but lack expression of the MITF target gene tyrosinase, which encodes the rate-limiting enzyme in melanin synthesis. Consequently, the cells remain unpigmented. Addition of cholera toxin, which elevates cAMP levels and mimics part of the KIT signaling pathway, increases the number of MITF-positive cells in Kit(W-LacZ)/Kit(W-LacZ) cultures, leads to tyrosinase expression, and induces the differentiation of melanoblasts into mature, pigmented melanocytes. Even when added on day 5-6 of culture, cholera toxin still rescues tyrosinase expression and differentiation. The results thus demonstrate that the presence of MITF is not sufficient for tyrosinase expression in melanoblasts and that KIT signaling influences gene expression during melanocyte development in a gene-selective manner.
This article has been cited by other articles:
|
|
 |
|
  G. Diwakar, D. Zhang, S. Jiang, and T. J. Hornyak Neurofibromin as a regulator of melanocyte development and differentiation J. Cell Sci., January 15, 2008; 121(2): 167 - 177. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Esumi, S. Kachi, P. A. Campochiaro, and D. J. Zack VMD2 Promoter Requires Two Proximal E-box Sites for Its Activity in Vivo and Is Regulated by the MITF-TFE Family J. Biol. Chem., January 19, 2007; 282(3): 1838 - 1850. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Hou, H. Arnheiter, and W. J. Pavan Interspecies difference in the regulation of melanocyte development by SOX10 and MITF PNAS, June 13, 2006; 103(24): 9081 - 9085. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Larribere, C. Hilmi, M. Khaled, C. Gaggioli, K. Bille, P. Auberger, J. P. Ortonne, R. Ballotti, and C. Bertolotto The cleavage of microphthalmia-associated transcription factor, MITF, by caspases plays an essential role in melanocyte and melanoma cell apoptosis Genes & Dev., September 1, 2005; 19(17): 1980 - 1985. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Sommer Checkpoints of Melanocyte Stem Cell Development Sci. Signal., August 23, 2005; 2005(298): pe42 - pe42. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-B. Ruan, N. Zhang, and X. Gao Identification of a Novel Point Mutation of Mouse Proto-Oncogene c-kit Through N-Ethyl-N-nitrosourea Mutagenesis Genetics, February 1, 2005; 169(2): 819 - 831. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. M. Wilson, K. L. Richards, M. L. Ford-Perriss, J.-J. Panthier, and M. Murphy Neural crest cell lineage segregation in the mouse neural tube Development, December 15, 2004; 131(24): 6153 - 6162. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Slominski, D. J. Tobin, S. Shibahara, and J. Wortsman Melanin Pigmentation in Mammalian Skin and Its Hormonal Regulation Physiol Rev, October 1, 2004; 84(4): 1155 - 1228. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Hou, W. J. Pavan, M. K. Shin, and H. Arnheiter Cell-autonomous and cell non-autonomous signaling through endothelin receptor B during melanocyte development Development, July 15, 2004; 131(14): 3239 - 3247. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Goodall, S. Martinozzi, T. J. Dexter, D. Champeval, S. Carreira, L. Larue, and C. R. Goding Brn-2 Expression Controls Melanoma Proliferation and Is Directly Regulated by {beta}-Catenin Mol. Cell. Biol., April 1, 2004; 24(7): 2915 - 2922. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Bejar, Y. Hong, and M. Schartl Mitf expression is sufficient to direct differentiation of medaka blastula derived stem cells to melanocytes Development, December 29, 2003; 130(26): 6545 - 6553. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Elworthy, J. A. Lister, T. J. Carney, D. W. Raible, and R. N. Kelsh Transcriptional regulation of mitfa accounts for the sox10 requirement in zebrafish melanophore development Development, June 15, 2003; 130(12): 2809 - 2818. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Sanchez-Martin, A. Rodriguez-Garcia, J. Perez-Losada, A. Sagrera, A. P. Read, and I. Sanchez-Garcia SLUG (SNAI2) deletions in patients with Waardenburg disease Hum. Mol. Genet., December 1, 2002; 11(25): 3231 - 3236. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Perez-Losada, M. Sanchez-Martin, A. Rodriguez-Garcia, M. L. Sanchez, A. Orfao, T. Flores, and I. Sanchez-Garcia Zinc-finger transcription factor Slug contributes to the function of the stem cell factor c-kit signaling pathway Blood, July 30, 2002; 100(4): 1274 - 1286. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Wilson, N. Nag, P. Davern, B. J. Oldfield, M. J. McKinley, U. Greferath, and M. Murphy Visualization of functionally activated circuitry in the brain PNAS, February 20, 2002; (2002) 42701199. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Raanani, J. M. Goldman, and I. Ben-Bassat Challenges in Oncology: Case 3. Depigmentation in a Chronic Myeloid Leukemia Patient Treated With STI-571 J. Clin. Oncol., February 1, 2002; 20(3): 869 - 870. [Full Text] [PDF]
|
|
|
|
|
|
Y. Wilson, N. Nag, P. Davern, B. J. Oldfield, M. J. McKinley, U. Greferath, and M. Murphy Visualization of functionally activated circuitry in the brain PNAS, March 5, 2002; 99(5): 3252 - 3257. [Abstract] [Full Text] [PDF]
|
|
